Device Trial Radar · NCT00586729
Vashe Wound Therapy Study
Last checked: Nov 20, 2026Latest source record: Sep 14, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
23
Actual
Start
Jul 2009
Primary completion
Nov 2010
Study completion Nov 2010
Sponsor
- Lead sponsor
- Valleywise HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- PuriCore, Inc.
- First posted
- Jan 4, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy, safety, and tolerability of topical Vashe™ Wound Therapy applied to gauze dressing every 6 hours or as necessary to keep dressing moist versus 5% Mafenide Acetate applied to gauze dressing every 6 hours or as necessary to keep dressing moist for a total treatment duration of 5 days.
Conditions
- Burns
Interventions
VasheDevice
Antimicrobial irrigant
Mafenide acetateDrug
Antimicrobial solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Grafted Area That is Viable at Day 14Time frame: 14 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Maricopa Integrated Health System
Phoenix, Arizona
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.